MBX-8025: Completed Phase II enrollment

Metabolex completed enrollment of 180 overweight or obese patients in a double-blind, U.S. Phase II trial evaluating 2 dose strengths of oral MBX-8025 with or without Lipitor atorvastatin from Pfize...